CRSP vs TPR · rev $11.6M vs P/E 46, rev $8.00B
Crispr Therapeutics AG (CRSP) versus Tapestry Inc (TPR) — a side-by-side from cached financials, not a winner call.
Crispr Therapeutics AG (CRSP) is a biotechnology company listed on US.
Tapestry Inc (TPR) is a luxury goods company listed on NYSE.
Latest reported CRSP revenue for 2026-06-30 was $11.6M. Net income was -$214.1M. CRSP currently screens at market cap $5.42B.
Latest reported TPR revenue for 2026-06-27 was $8.00B. Net income was $1.53B. Revenue was up 14.2% from 2025-06-28 to 2026-06-27. TPR currently screens at market cap $30.81B and trailing P/E 46.3.
CRSP currently screens at market cap $5.42B. TPR currently screens at market cap $30.81B and trailing P/E 46.3.
Not investment advice. Open the CRSP and TPR stock pages for the full models.
Not investment advice.